BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Taiwan

Senhwa Biosciences' Silmitasertib Receives Rare Pediatric Disease Designation from US FDA for Neuroblastoma

Senhwa Biosciences, Inc. (TPEx: 6492), a new drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and infectious d...

September 13, 2024 | News

Acepodia Partners with Pfizer Ignibiolote to Advance Cell Therapies for Autoimmune Diseases and Oncology

Through Pfizer Ignite, Acepodia will gain access to Pfizer's resources, scale and expertise as the company broadens the application of its platform beyon...

September 04, 2024 | News

Zuellig Pharma Secures Exclusive Distribution Agreement with Regeneron to Launch Libtayo® in South Korea and Taiwan

Zuellig Pharma, a leading healthcare solutions company in Asia, has announced an exclusive distribution agreement with Regeneron Ireland DAC, a wholly owne...

August 28, 2024 | News

Formosa Pharmaceuticals and Eyenovia to Co-Develop Clobetasol Propionate for Dry Eye Disease

Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TWO) announced today that the company has signed a non-binding terms agreement with Eyenovia, Inc. ("...

August 08, 2024 | News

Senhwa Biosciences Receives FDA Green Light for Phase I/II Trial of Silmitasertib in Pediatric Relapsed Refractory Solid Tumors

Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and infectious disea...

August 07, 2024 | News

Taiwan's Global Confluence of Biotech Innovation and Investment: BioAsia Taiwan 2024

BioAsia Taiwan 2024, a paramount event in the global biotech calendar, recently wrapped up a compelling three-day summit, attracting top-tier professionals...

July 29, 2024 | News

Senhwa Biosciences Submits IND to FDA for Phase I/II Trial of Silmitasertib in Pediatric Relapsed Refractory Solid Tumors

Senhwa Biosciences, Inc. (TPEx: 6492), announced IND Submission to US FDA for the Phase I/II study of Silmitasertib (CX-4945) in combination with chemother...

July 15, 2024 | News

Thermo Fisher Scientific Opens First Electron Microscopy Demo Center in Taiwan to Propel Semiconductor Innovation

To support next-generation semiconductor and materials innovation, Thermo Fisher Scientific today announced the opening of its first electron microscopy de...

July 10, 2024 | News

HiRO Acquires DeltaMed Solutions, Expands Across 10 Countries

Harvest Integrated Research Organization (HiRO), a full-service, boutique global CRO, is excited to announce its latest strategic move with the successful ...

July 02, 2024 | News

MLB Receives FDA Approval for TML-6 IND Application to Treat Alzheimer's Disease

MLB (Merry Life Biomedical Company, Ltd., Taiwan ) a biomedical company, announced that the U.S. Food and Drug Administration (FDA) h...

June 07, 2024 | News

Wistron and imedtac Collaborate with CMUH to Promote Advanced Medical Solutions in Malaysia

China Medical University Hospital (CMUH, Taiwan) and the Malaysian International Medical University (IMU), the first and top private medical and heal...

June 03, 2024 | News

Formosa Pharmaceuticals Strikes Exclusive Licensing Deal with Tabuk for Innovative Eye Surgery Drug in MENA

Taiwan-based Formosa Pharmaceuticals announced that the company has entered into an exclusive licensing agreement with Tabuk Pharmaceuticals Manufacturing ...

May 10, 2024 | News

CMUH and Microsoft Azure Introduce "gHi System" for AI-Assisted Medical Documentation

China Medical University Hospital (CMUH) and Microsoft Taiwan announced the Generative Healthcare Intelligent (gHi) System, which is being applied to ...

April 03, 2024 | News

Roche Taiwan Joins Forces with TTY Biopharm, Ushering in a New Dawn for Cancer Care

Roche Taiwan has announced a pioneering partnership with TTY Biopharm Company Limited, aiming to broaden its influence in the fight against cancer in Taiwa...

March 27, 2024 | News

Stay Connected